In human lung adenocarcinoma A549 cells, upregulation of GLIPR1 stimulated cell proliferation by inducing the increased expression of Bcl-2, thus increasing resistance to the chemotherapeutic drug cisplatin[130]. This evidence concerns the gene GLIPR1 and lung adenocarcinoma.